Kymera Therapeutics - Stock Price History | KYMR

Historical daily share price chart and data for Kymera Therapeutics since 2021 adjusted for splits. The latest closing stock price for Kymera Therapeutics as of September 27, 2021 is 63.59.
  • The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
  • The Kymera Therapeutics 52-week high stock price is 91.92, which is 44.6% above the current share price.
  • The Kymera Therapeutics 52-week low stock price is 27.65, which is 56.5% below the current share price.
  • The average Kymera Therapeutics stock price for the last 52 weeks is 52.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Kymera Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 43.2263 33.2600 87.8300 26.1000 62.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.246B $0.034B
Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29